Evidence map›Paper›PMID 37095058›Full record

ArticleCancer reports (Hoboken, N.J.)2023

Leiomyosarcoma, a rare smooth muscle cancer in the pancreas: An adjuvant radiotherapy treatment approach.

Ali Taghizadeh Kermani, Alireza Khooei, Mohsen Aliakbarian, Soudeh Arastouei

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer reports (Hoboken, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ali Taghizadeh KermaniCancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Alireza KhooeiDepartment of Pathology, Faculty of medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mohsen AliakbarianMashhad transplant research Center, Clinical research institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Soudeh ArastoueiCancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.ORCID 0000-0002-1087-9982
Mashhad University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLeiomyosarcoma of visceral organs is uncommon, and pancreatic primary occurrence is even rarer. In terms of curative treatment, patients are generally managed with surgery alone, without significant data on the role or efficacy of adjuvant chemotherapy. CASE PRESENTATION: This manuscript presents a case of a 22-year-old female with advanced primary leiomyosarcoma of the pancreas, treated with radical surgery and adjuvant radiation therapy.

conclusionWith a low-survival rate, consideration of radiation therapy in some advanced and unresectable cases could be potentially beneficial.

Indexed as

LeiomyosarcomaMuscle NeoplasmsAdultCombined Modality TherapyFemaleHumansPancreasRadiotherapy, AdjuvantYoung Adultadjuvantleiomyosarcomaleiomyosarcoma of pancreasmesenchymal tumoroncologypancreasradiotherapy

Identifiers

PMID37095058
PMCPMC10242651
OpenAlexW4366814125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.